Table 1.
Demography, pharmacotherapy, common multimorbid diseases, physical–mental health co-morbidity and 1-year mortality by number of diagnoses
| Number of diagnoses | |||||
|---|---|---|---|---|---|
| All | 0–1 | 2–4 | 5–9 | 10+ | |
| N (%) | 2 323 667 (100%) | 1 822 056 (78.4%) | 424 489 (18.3%) | 75 305 (3.2%) | 1817 (0.1%) |
| Sex | |||||
| Female | 1 162 569 (50.0%) | 884 840 (48.6%) | 238 850 (56.3%) | 38 089 (50.6%) | 790 (43.5%) |
| Male | 1 161 098 (50.0%) | 937 216 (51.4%) | 185 639 (43.7%) | 37 216 (49.4%) | 1027 (56.5%) |
| Age | |||||
| 0–9 | 295 754 (12.7%) | 286 529 (15.7%) | 9204 (2.2%) | 21 (0.03%) | 0 (0%) |
| 10–19 | 258 750 (11.1%) | 241 006 (13.2%) | 17 538 (4.1%) | 206 (0.3%) | 0 (0%) |
| 20–29 | 320 453 (13.8%) | 289 557 (15.9%) | 29 946 (7.1%) | 950 (1.3%) | 0 (0%) |
| 30–39 | 350 272 (15.1%) | 312 669 (17.2%) | 36 113 (8.5%) | 1481 (2.0%) | 9 (0.5%) |
| 40–49 | 327 025 (14.1%) | 2781 13 (15.3%) | 46 153 (10.9%) | 2742 (3.6%) | 17 (0.9%) |
| 50–59 | 289 043 (12.4%) | 215 439 (11.8%) | 66 978 (15.8%) | 6560 (8.7%) | 66 (3.6%) |
| 60–69 | 219 562 (9.5%) | 123 922 (6.8%) | 82 976 (19.6%) | 12 450 (16.5%) | 214 (11.78) |
| 70–79 | 174 220 (7.5%) | 60 800 (3.3%) | 89 295 (21.0%) | 23 563 (31.3%) | 562 (30.9%) |
| 80–89 | 70 159 (3.0%) | 11 903 (0.7%) | 37 139 (8.8%) | 20 383 (27.1%) | 734 (40.4%) |
| 90–99 | 17 963 (0.8%) | 2042 (0.1%) | 8904 (2.1%) | 6803 (9.0%) | 214 (11.8%) |
| 100+ | 466 (0.0%) | 76 (0.0%) | 243 (0.06%) | 146 (0.2%) | 1 (0.06%) |
| Number of medications | |||||
| 0–4 | 1 762 514 (75.9%) | 1 607 117 (88.2%) | 152 043 (35.8%) | 3337 (4.4%) | 17 (0.9%) |
| 5–9 | 365 566 (15.7%) | 180 121 (9.9%) | 167 089 (39.4%) | 18 288 (24.3%) | 68 (3.7%) |
| 10–14 | 125 794 (5.4%) | 27 816 (1.5%) | 72 501 (17.1%) | 25 200 (33.5%) | 277 (15.2%) |
| 15+ | 69 793 (3.0%) | 7002 (0.4%) | 32 856 (7.7%) | 28 480 (37.8%) | 1455 (80.1%) |
| Common multimorbid diseases | |||||
| Heart failure | 36 444 (1.6%) | 574 (0.03%) | 12 621 (3.0%) | 21 905 (29.1%) | 1344 (74.0%) |
| Chronic renal disease | 25 443 (1.1%) | 1303 (0.07%) | 10 417 (2.5%) | 12 816 (17.0%) | 907 (49.9%) |
| Coronary heart disease | 63 778 (2.7%) | 3292 (0.2%) | 32 842 (7.7%) | 26 382 (35.0%) | 1262 (69.5%) |
| Atrial fibrillation | 58 841 (2.5%) | 3997 (0.2%) | 28 064 (6.6%) | 25 582 (33.0%) | 1198 (65.9%) |
| COPD | 48 620 (2.1%) | 5406 (0.3%) | 25 644 (6.0%) | 16 613 (22.1%) | 957 (52.7%) |
| Stroke/TIA | 42 027 (1.8%) | 2826 (0.2%) | 21 260 (5.0%) | 17 067 (22.7%) | 874 (48.1%) |
| Dementia | 18 202 (0.8%) | 1329 (0.07%) | 9497 (2.2%) | 7050 (9.4%) | 326 (17.9%) |
| Peripheral vascular disease | 14 220 (0.6%) | 1896 (0.1%) | 6633 (1.6%) | 5326 (7.1%) | 365 (20.1%) |
| Bronchiectasis | 2411 (0.1%) | 282 (0.02%) | 1269 (0.3%) | 801 (1.1%) | 59 (3.3%) |
| Hypertension | 334 935 (14.4%) | 69 061 (3.8%) | 201 517 (47.5%) | 62 623 (83.2%) | 1734 (95.4%) |
| Diabetes | 105 534 (4.5%) | 13 141 (0.7%) | 63 300 (14.9%) | 27 997 (37.2%) | 1096 (60.3%) |
| Cancer | 98 369 (4.23%) | 20 068 (1.1%) | 54 844 (12.9%) | 22 590 (30.0%) | 867 (47.7%) |
| Physical–mental health co-morbidity | 133 942 (5.8%) | 0 (0%) | 102 069 (24.1%) | 30 810 (40.9%) | 1063 (58.5%) |
| Anxiety disorders | 131 088 (5.6%) | 41 659 (2.3%) | 75 458 (17.8%) | 13 516 (18.8%) | 455 (25.0%) |
| Depression | 72 286 (3.1%) | 14 165 (0.8%) | 46 662 (11.0%) | 11 061 (14.7%) | 398 (21.9%) |
| Alcohol problems | 60 671 (2.6%) | 17 441 (1.0%) | 33 347 (7.9%) | 9529 (12.7%) | 354 (19.5%) |
| Substance misuse | 30 591 (1.3%) | 7434 (0.4%) | 18 035 (4.3%) | 4888 (6.5%) | 234 (12.9%) |
| 1-Year mortality | 15 842 (0.7%) | 2315 (0.1%) | 7122 (1.7%) | 6054 (8.0%) | 351 (19.3%) |